Over 1,300 faculty are affiliated with Stanford Bio-X and are eligible to apply for our grants and be notified about fundraising opportunities, collaborations with industries, events, courses and available facilities and instruments. Learn how to become an affiliate!
Dr. Jason Sheltzer received a Ph.D. in Biology from the Massachusetts Institute of Technology. His research interests include aneuploidy, genomic instability, mitotic kinases, molecular pharmacology, and genome engineering.
Dr. Natalie Larson's lab develops hybrid manufacturing methods (e.g., multimaterial 3D printing with subvoxel control) and applies in-situ characterization techniques (e.g., 4D X-ray computed tomography) to investigate new classes of hierarchical architected materials. The Lab aims to enable sustainable fabrication of multimaterial and composite systems with enhanced properties, including efficiency and multifunctionality, for applications in aerospace, transportation, soft robotics, and healthcare.
Dr. Siddharth Krishnan is an Assistant Professor of Electrical Engineering at Stanford University. Prior to this, he was a K99-funded Research Scientist in the groups of Prof. Daniel Anderson and Prof. Robert Langer at the Koch Institute for Integrative Cancer Research at MIT and at Boston Children's Hospital. He received BS and MS degrees from Washington University in St. Louis, and his PhD from the University of Illinois at Urbana-Champaign from Prof. John Rogers' group. His work has focused on the development of bioelectronic devices for sensing and therapeutics.
Dr. Kenneth Weber's research seeks to develop markers of pain and sensorimotor function using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of pain and neurological conditions and discover more effective treatments and preventative strategies.
For the past 20 years most of Dr. Christopher Gardner's research has been focused on investigating the potential health benefits of various dietary components or food patterns using randomized controlled trials. The interventions have involved vegetarian diets, soy, garlic, omega-3 fats/fish oil/flax oil, antioxidants, Ginkgo biloba, and popular weight loss diets. These trials have studied outcomes that include weight, blood lipids and lipoproteins, inflammatory markers, glucose, insulin, and body composition. Most of these trials have been NIH-funded.
Dr. Kevin Chuen Wing Chan is an Associate Professor of Ophthalmology and the Director of the Neuroimaging and Visual Science Laboratory at Stanford University School of Medicine. Dr. Chan's laboratory focuses on developing and applying new, non-invasive methods for imaging neurodegeneration, neurodevelopment, neuroprotection, neuroplasticity, and neuroregeneration in vision-related diseases and injuries to guide vision preservation and restoration.
Dr. Rongxin Fang received his Ph.D. in Bioinformatics and Systems Biology at UC San Diego, where he was advised by Bing Ren (2015-2019). During this time, he developed high-throughput genomic technologies and computational tools to map the structure and activity of the mammalian genome at a large scale with single-cell resolution.
Dr. Sabine Heitzeneder’s research bridges the rational discovery of promising, tumor-restricted target antigens expressed on childhood cancer, that are absent from normal, vital tissue in the body and the robust pre-clinical development of adoptive cellular immunotherapies tailored to these antigens, that are suitable for phase I clinical testing in patients.
Shannon received her B.S. in Chemistry from National Taiwan University. She then pursued her Ph.D. in Chemistry at UC Berkeley with Prof. Ignacio Tinoco, Jr. and studied ribosome translation dynamics (Cell 2015) using mass spectrometry and force spectroscopy with optical tweezers. During postdoc with Prof. Carlos Bustamante, also at UC Berkeley, Dr.
Dr. Maayan Levy received her Ph.D. in Immunology from the Weizmann Institute of Science. After completion of her PhD, Dr. Levy became an Assistant Professor at the Microbiology Department of the Perelman School of Medicine at the University of Pennsylvania. Dr. Levy has recently joined the Stanford Medicine Department of Pathology as an Assistant Professor and the Arc Institute as an Innovation Investigator in Residence.
